Abstract

BACKGROUND CONTEXT The role of early surgical decompression in traumatic central cord syndrome (TCCS) remains controversial. With the aging population, TCCS is expected to become the most common form of acute traumatic spinal cord injury (SCI), making the identification of treatment strategies that mitigate disability in this vulnerable population a key public health priority. PURPOSE To evaluate the impact of time to surgery on clinical outcomes in patients with TCCS. STUDY DESIGN/SETTING Analysis of prospective data from two multicenter international acute traumatic SCI datasets: 1) the NACTN SCI Registry; and 2) the STASCIS dataset. PATIENT SAMPLE Patients with TCCS, defined by at least a 10-point difference between the initial ASIA upper extremity motor score (UEMS) and ASIA lower extremity motor score (LEMS) in favor of the lower limbs (LEMS–UEMS≥10). OUTCOME MEASURES Motor recovery and functional outcome, as evaluated by the ASIA total motor score (AMS) and functional independence measure (FIM) motor subscore, respectively. Outcomes were evaluated at 6 months. The primary outcome was change in AMS. Secondary outcomes were ASIA impairment scale (AIS) conversion (≥1 grade improvement), change in FIM motor subscore, and development of complications. METHODS Baseline characteristics and outcomes were compared in patients who underwent early ( RESULTS Seventy-three patients met criteria, with 28 (38.4%) undergoing early surgery. Mean improvement in AMS at 6 months was greater in the early (30.4 points) than delayed (20.9 points) surgery group (P=.045). Early surgery was also associated with greater improvement in FIM motor subscore (38.2 vs. 20.3 points, P=.006). There was no significant difference in rates of AIS conversion (P=.265) or complications (P=.139). On multiple linear regression, initial AMS (P CONCLUSIONS Early surgical decompression is safe and effective in patients with TCCS. Shorter time to surgery positively impacts motor recovery in TCCS; this effect is most pronounced in patients with AIS C injuries, those without instability, and especially in patients with stable AIS C injuries. FDA DEVICE/DRUG STATUS This abstract does not discuss or include any applicable devices or drugs.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.